FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults Read more
Forge Biologics and Labcorp Announce Strategic AAV Gene Therapy Development and Manufacturing Collaboration Read more
Kamada Announces U.S. FDA Approval of its Application to Manufacture CYTOGAM at the Company’s Facility in Israel Read more
Full-Life Technologies Announces Land Purchase in Belgium to Establish GMP Manufacturing Facility for Radiopharmaceutical Drug Production Read more
Vertex’s KALYDECO (ivacaftor) Receives FDA Approval for Treatment of Cystic Fibrosis in Infants as Young as 1 Month Old Read more
Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy Read more
BrightPath Biotherapeutics and Artisan Bio Announce Research and Licensing Agreement to Accelerate Development of BrightPath’s Novel Allogeneic iPSC Derived Cell Therapy Platform across Multiple Indications Read more
FDA Grants Accelerated Approval for QALSODY (tofersen) for SOD1-ALS, a Major Scientific Advancement as the First Treatment to Target a Genetic Cause of ALS Read more